KZA 0.00% 8.0¢ kazia therapeutics limited

novogen making a comeback

  1. 3,567 Posts.
    Biotechs are very much returning as investor favourites and the blue chip in the sector i.e. Novogen is looking great on the charts. The recent appointment of a "deal maker" to the board adds weight to arguements that we'll see a deal sooner rather than later.

    Only a few weeks to see the full year result and then a few more till the AGM. Expect the AGM to start a buying spree in the stock.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.